Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...

In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

CRISPR became big in 2025, bringing advances for serious Indian health risks, which will continue in the coming year ...

A child who received the world's first personalized CRISPR therapy is now taking his first steps after months in hospital ...

CRISPR Therapeutics shares early autoimmune and lymphoma data for zugo-cel, showing strong responses, manageable safety, and expanded oncology plans.

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

CRISPR has incurred nearly $500 million in losses over the past four quarters. It's burning through cash as the result of its ...

A miracle baby who was treated with a pioneering gene-therapy at CHOP has reached a major milestone as he took his first ...

CRISPR Therapeutics reached a significant milestone a couple of years ago: its first product approval. The company’s stock, ...

Talk about a Christmas miracle!A medical breakthrough came just in time and changed one baby’s life — and gave his family a ...